At a glance
Type: Multi-receptor agonist peptide (research literature)
Category: Metabolic pathway research
Alternate names: GLP-3 RT, LY3437943, Triple agonist peptide (research literature)
Historical context
Retatrutide (LY3437943) advanced through Eli Lilly clinical development pipelines; research supply interest focuses on reference material for analytical and preclinical model work — not clinical use.
Active research areas
Receptor binding assays
Glucose homeostasis models (preclinical)
Energy expenditure literature reviews
In vitro receptor pharmacology
Material availability
VaultLabs catalog SKUs: glp-3-rt-10mg — view product pages for current AED pricing and lot documentation.
COA verification available per batch when published to the documentation portal.
Catalog alignment
VaultLabs GLP-3 RT 10mg maps to retatrutide-class research material with batch COA when published.
We do not provide dosing, administration, or weight-management guidance — research documentation only.